COMP <GO>
LNTH vs ABBV // ALTMAN Z-SCORE & DEBT/EQUITY
Lantheus Holdings Inc. (NASDAQ) VS. AbbVie Inc. (NYSE) • 15-METRIC TALLY: LNTH 6
— ABBV 8
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: LNTH
LAST: $100.46 (+0.14%) • MKT CAP: $6.55B
balance-sheet
5.34
LAST: $294.89 (+1.41%) • MKT CAP: $513.86B
balance-sheet
5.33
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LNTH VS. ABBV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | LNTH | ABBV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 61.10% | 70.20% | -9.10 | ABBV | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 20.30% | 29.00% | -8.70 | ABBV | /roic <GO> |
| EV/EBITDA & P/E Valuation | 18.0x | 33.3x | -15.30 | LNTH | /valuation <GO> |
| Free Cash Flow Yield | 4.90% | 3.47% | +1.43 | LNTH | /fcf-yield <GO> |
| Operating Margin | 20.20% | 24.60% | -4.40 | ABBV | /operating-margins <GO> |
| Net Profit Margin | 15.20% | 6.90% | +8.30 | LNTH | /net-margins <GO> |
| Revenue Growth (YoY) | 0.50% | 8.60% | -8.10 | ABBV | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.27% | -2.27 | ABBV | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 5.34 | 5.33 | +0.01 | LNTH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.50% | 7.40% | -0.90 | LNTH | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 56.0 | 72.8 | -16.73 | ABBV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.88 | 1.15 | -0.27 | ABBV | /macro-sensitivity <GO> |
| Forward P/E Multiple | 26.0x | 113.1x | -87.10 | LNTH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $6.55B | $513.86B | -$507.31B | ABBV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | LNTH REV | ABBV REV | LNTH GROSS % | ABBV GROSS % | LNTH FCF | ABBV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.54B | $61.16B | 61.1% | 70.2% | $320.8M | $17.82B |
| FY 2024 | $1.53B | $56.33B | 64.4% | 70.0% | $475.7M | $17.83B |
| FY 2023 | $1.30B | $54.32B | 44.0% | 44.0% | $246.9M | $20.39B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LNTH // BETA 0.88
ABBV // BETA 1.15